Mitochondrial FIS1 As a Novel Drug Target for the Treatment of Erectile Dysfunction: A Multi-Omic and Epigenomic Association Study
Purpose: Mitochondrial dysfunction may impact male erectile function, but the underlying genetic mechanisms remain unclear. The study aims to investigate the causal role for genetically regulated mitochondrial function in erectile dysfunction (ED) and to identify potential drug targets for the tre...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Society for Sexual Medicine and Andrology
2025-07-01
|
| Series: | The World Journal of Men's Health |
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Purpose: Mitochondrial dysfunction may impact male erectile function, but the underlying genetic mechanisms remain unclear.
The study aims to investigate the causal role for genetically regulated mitochondrial function in erectile dysfunction (ED)
and to identify potential drug targets for the treatment of ED.
Materials and Methods: The data of gene methylation, gene expression and protein level related to mitochondria were extracted
from the corresponding genome-wide association studies (GWAS) database. Discovery and validation datasets for ED
were sourced from research by Bovijn et al, the FinnGen database, and the UK Biobank. We performed summary-data-based
Mendelian randomization analysis, colocalization analysis, as well as molecular prediction and molecular docking analysis
to assess the association between mitochondrial dysfunction and ED. We also identified relevant targets and potential molecules
for the treatment of ED.
Results: Through the integration of multi-omics results, we identified an inverse relationship between the expression of the
mitochondrial-related gene FIS1 and the risk of ED (odds ratio [OR]: 0.89, 95% confidence interval [CI]: 0.81–0.97, p-value
of summary-data-based Mendelian randomization analysis [PSMR]=1.01×10-2). In FIS1, methylation of cg19802458 and
cg08601038 was related to high expression of the FIS1 gene, which is consistent with the protective effects of cg19802458
and cg08601038 methylation against ED. Additionally, elevated levels of FIS1 protein displayed a negative association with ED
risk (OR: 0.71, 95% CI: 0.55–0.92, PSMR=1.00×10-2). Molecular prediction and molecular docking analysis revealed that resveratrol
and quercetin had protective effects against ED by targeting FIS1, and had good affinity and binding mode with FIS1,
respectively.
Conclusions: This study demonstrated the causal relationship between the mitochondrial FIS1 gene and ED risk and found
that resveratrol and quercetin may have therapeutic effects on ED. These discoveries offer fresh perspectives on the pathogenesis
of ED and propose preliminary candidate targets and drugs for future treatment of ED. |
|---|---|
| ISSN: | 2287-4208 2287-4690 |